Archive | January 2016

Ronald W. Lindsey Named Co-Editor of JBJS Case Connector

MarcDr. Lindsey1 Swiontkowski, MD, Editor-in-Chief of The Journal of Bone & Joint Surgery (JBJS) and Co-Editor of JBJS Case Connector, has announced that, effective January 1, 2016, Ronald W. Lindsey, MD, will join Tom Bauer, MD as Co-Editor of Case Connector. Dr. Swiontkowski will step down from his role as Case Connector Co-Editor but will remain as Editor-in Chief of JBJS. “I am confident that Ron and Tom will help move Case Connector into position as a foremost resource for clinicians seeking guidance and information on rare and unusual conditions from across the globe,” said Dr. Swiontkowski.

Dr. Lindsey is a Professor of Orthopaedic Surgery & Rehabilitation and Chair of the Department of Orthopaedic Surgery & Rehabilitation at the University of Texas Medical Branch, as well as a former Associate Editor for JBJS. After receiving his medical degree from Columbia University College of Physicians and Surgeons and completing an orthopaedic residency at Yale-New Haven Hospital, Dr. Lindsey pursued several fellowships at prestigious European orthopaedic institutions, including AO and spine fellowships at the University of Basel, and a spine fellowship at the University of Marseilles.

“I look forward to working with Dr. Bauer and the JBJS Case Connector editorial board to continue building a premier online database of peer-reviewed orthopaedic cases and the technology that enables orthopaedists to efficiently filter case information,” said Dr. Lindsey.  “Our goal will always be to assist orthopaedic surgeons in the search for clinical precedents, connections, and trends in their efforts to improve patient care.”

JBJS Reviews Editor’s Choice–VTED after Foot and Ankle Surgery

It seems that anytime a lower extremity undergoes operative treatment, the question is raised regarding the need for and type of thromboprophylaxis. However, controversy exists regarding the use of prophylaxis against venous thromboembolic disease (VTED) after foot and ankle surgery, largely because there are insufficient data from large-scale randomized trials to help guide foot and ankle surgeons in their decision-making processes. Currently, foot and ankle surgeons are forced to make decisions on the basis of incomplete information and contradictory guidelines. Moreover, there is inaccuracy in extrapolating findings from hip and knee arthroplasty studies to the foot and ankle population.

In the December 2015 issue of JBJS Reviews, Guss and DiGiovanni review VTED in the setting of foot and ankle surgery and recognize that certain patient populations may be at higher risk, including patients over the age of forty years with acute Achilles tendon ruptures, patients over the age of fifty years with ankle fractures, patients with diabetes mellitus, patients with connective-tissue inflammatory diseases, and patients with a history of VTED. They also consider associated factors such as the use of oral contraceptives, cigarette smoking, recent air travel, and a family history of VTED. They emphasize that there have been limited randomized controlled trials addressing the question of thromboprophylaxis after foot and ankle surgery and that current data suggest that the use of chemoprophylaxis against VTED in patients undergoing foot and ankle surgery may not necessarily lower the incidence of VTED events. Large-scale postoperative randomized trials are necessary to better guide foot and ankle surgeons in their decision-making processes regarding thromboprophylaxis after surgery. As a result, current foot and ankle surgeons continue to have to make decisions on the basis of incomplete information and contradictory guidelines.

In order to provide some clarity to these issues, specialty societies and associations, including the American College of Chest Physicians and the American Academy of Orthopaedic Surgeons, have issued recommendations regarding the appropriate use of prophylaxis against VTED in the postoperative period. However, these guidelines are largely based on literature of variable quality and applicability. For example, there is no agreement on the appropriate framework for risk-benefit analysis of these issues. Furthermore, unlike the American College of Chest Surgeons and the American Academy of Orthopaedic Surgeons, the American Orthopaedic Foot & Ankle Society has repeatedly expressed its inability to provide any guidance because of the lack of available information.

The literature examining the incidence of VTED after foot and ankle surgery is limited. Nevertheless, clinicians must make decisions against the backdrop of global quality initiatives that consider VTED to be a preventable event.

Thomas Einhorn, MD

Editor, JBJS Reviews